Diffusion tensor imaging reveals changes in non-fat infiltrated muscles in late onset Pompe disease

Muscle Nerve. 2020 Oct;62(4):541-549. doi: 10.1002/mus.27021. Epub 2020 Jul 31.

Abstract

MRI is a helpful tool for monitoring disease progression in late-onset Pompe disease (LOPD). Our study aimed to evaluate if muscle diffusion tensor imaging (mDTI) shows alterations in muscles of LOPD patients with <10% fat-fraction. We evaluated 6 thigh and 7 calf muscles (both legs) of 18 LOPD and 29 healthy controls (HC) with muscle diffusion tensor imaging (mDTI), T1w, and mDixonquant sequences in a 3T MRI scanner. The quantitative mDTI-values axial diffusivity (λ1 ), mean diffusivity (MD), radial diffusivity (RD), and fractional anisotropy (FA) as well as fat-fraction were analyzed. 6-Minute Walk Test (6-MWT) data were correlated to diffusion metrics. We found that mDTI showed significant differences between LOPD and HC in diffusion parameters (P < .05). Thigh muscles with <10% fat-fraction showed significant differences in MD, RD, and λ1-3 . MD positively correlated with 6-MWT (P = .06). To conclude, mDTI reveals diffusion restrictions in muscles of LOPD with and without fat-infiltration and reflects structural changes prior to fatty degeneration.

Keywords: 6-Minute Walk Test; diffusion tensor imaging; glycogen storage disease type II; magnetic resonance imaging; muscle, skeletal; tractography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Diffusion Tensor Imaging
  • Female
  • Glycogen Storage Disease Type II / diagnostic imaging*
  • Humans
  • Leg / diagnostic imaging*
  • Male
  • Middle Aged
  • Muscle, Skeletal / diagnostic imaging*
  • Thigh / diagnostic imaging*
  • Young Adult